公司资料
ProPhase Labs 股价、新闻与催化剂
- 股票代码:
- PRPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.03 USD (-25.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
As of Aug 17, 2026, PRPH closed down 25.0% at $0.0300. No new same-company headline was identified in the current news window.
公司概览
业务概览
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, ProPhase sits in consumer health and diagnostics.
商业模式特征
The company depends on product and test adoption, commercial execution, and the ability to monetize a small portfolio of assets.
生物医药行业定位
ProPhase is outside biotech proper and belongs to the consumer-diagnostics and health-products layer.
未来催化剂
- ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction. Investors will care about whether the business can find a stable growth path.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。